Posology: The primary vaccination schedule consists of three doses in the first year of life and can start from the age of 2 months. An interval of at least 1 month should be respected between subsequent doses.
When the primary course is completed before the age of 6 months, a booster dose can be given in the second year of life. An interval of at least 6 months after completion of primary vaccination schedule should be respected. Data on the use of the vaccine as a booster has been obtained for children up to the age of 13 years.
Infanrix-IPV should be used in accordance with available official recommendations.
Method of administration: Infanrix-IPV is for deep intramuscular injection. For infants, the preferred site of injection is the anterolateral aspect of the thigh; in older children, vaccine should be administered in the deltoid.
It is preferable that each subsequent dose is given at alternate sites.
Infanrix-IPV should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramascular administration to these subjects. Firm pressure should be applied to the injection site (without rubbing) for at least two minutes.